GreenHouse Holdings, Inc. (OTCQB:GRHU), a San Diego, California based integrated energy solutions provider and developer of eco-friendly infrastructure, announced the signing of a Letter of Intent to acquire Control Engineering, Inc (NYSEMKT:CEI).
Key Strategic Benefits for GreenHouse include: The acquisition is expected to significantly increase gross margins in GreenHouse's Energy Services Division via vertical integration of CEI's business. The acquisition is also expected to provide cross-selling opportunities of GreenHouse products and services to CEI's existing clients; The acquisition should immediately give GreenHouse access to the expert knowledge of CEI in commercial and industrial automation; and The anticipated cost saving as a result of the acquisition will provide a competitive advantage to GreenHouse in the Automated Demand Response market.
CEI's team members are expected to stay in their current or similar roles and will work directly with GreenHouse executives to manage the integration and restructuring of CEI's operations with GreenHouse's. GreenHouse will provide its expectations of when the transaction is projected to close and provide specific revenue and earnings per share guidance in a future announcement.
GreenHouse Holdings, Inc. is a San Diego, California based integrator of some of the world's most innovative environmental, public safety, infrastructure technologies. GreenHouse provides systems that are financially sound and sustainable to residential, commercial, industrial and government markets around the globe.
GreenHouse provides energy-efficiency products, energy management systems, eco-friendly infrastructure, scalable waste-to-fuel bio-fuel and closed loop systems, as well as other proprietary technologies and products that are utilized to provide a greener and safer future for millions of people.
Catalyst Rx, the pharmacy benefit management subsidiary of Catalyst Health Solutions, Inc. (NASDAQ:CHSI), disclosed the award of a PBM contract by Ford Motor Company for its salaried employees and non-Medicare retirees. The new contract, effective January 1, 2011, covers approximately 40,000 lives.
Catalyst Health Solutions, Inc. is built on strong, innovative principles in the management of prescription drug benefits and provides an unbiased, client-centered philosophy resulting in industry-leading client retention rates.
Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) released that its investigational drug, CPP-115, a novel GABA aminotransferase inhibitor, has been granted orphan-drug designation for the treatment of infantile spasms by the U.S. Food and Drug Administration.
Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company focused on the development and commercialization of prescription drugs targeting addictions and diseases of the central nervous system, such as epilepsy and neuropathic pain.
The Cato Corporation (NYSE:CATO) reported sales of $72.1 million for the five weeks ended October 2, 2010, a 3% increase over sales of $70.0 million for the five weeks ended October 3, 2009. Same-store sales for the five-week period increased 2% over the prior year.
Sales for the thirty-five weeks ended October 2, 2010 were $625.6 million, a 6% increase over sales of $592.5 million for the thirty-five weeks ended October 3, 2009. Cato's year-to-date same-store sales increased 4%.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (GRHU). In addition to the cash, Crown Equity Holdings Inc. (OTCPK:CRWE) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.